Other non-current assets

12 Months Ended

Dec. 31, 2020

Other non-current assets

Other non-current assets

17.   Other non-current assets

As at December 31,	2020		2019
Right-of-use assets	$	116,503	$	116,209
Tax receivable		11,050		11,792
Loans receivable		4,870		—
Equity-accounted investments		—		4,276
Deferred debt issue costs		2,263		1,403
Other		12,922		11,999
	$	147,608	$	145,679

Loans receivable

During the year ended December 31, 2020, the Company entered into two non-recourse financing lending arrangements which are fully collateralized and secured by certain equipment. These financing lending arrangements have a term of two to four years. In the event of default, the Company is obligated to take possession of the equipment under the agreements to recover its loans receivable balance. As at December 31, 2020, the loans receivable balance of such financing lending arrangements was $5,797,000 (of which $927,000 is recorded in other current assets) and the expected credit loss allowance was not significant.

17.   Other non-current assets (continued)

Equity-accounted investments

The Company held a 48% share interest in a group of companies detailed below (together, the “Cura Classis entities”), which had common ownership. The Cura Classis entities provided dedicated fleet management services in three jurisdictions to a common customer unrelated to the Company. The Company has previously determined that the Cura Classis entities were variable interest entities and that the Company was not the primary beneficiary, as it did not have the power to make any decisions that significantly affect the economic results of the Cura Classis entities. Accordingly, the Company accounted for its investments in the Cura Classis entities following the equity method.

A condensed summary of the Company’s investments in and advances to equity-accounted investees are as follows:

	Ownership		December 31,		December 31,
(in U.S. $000's, except percentages)	percentage		2020		2019
Cura Classis entities	48	%	$	—	$	4,276

During the year ended December 31, 2020, the Company received a final distribution of its equity-accounted investments in the Cura Classis entities. The transaction did not result in a significant gain or loss. The Company has no other business relationships with the Cura Classis entities.